ArticleJournal of diabetes investigation2025

Glucagon-like pepetide-1 receptor agonist suggests novel therapeutic options for hypothalamic obesity.

Wanlu Ma et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.